AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 18-E-12-004.01
CMS should seek a legislative change that would provide the agency flexibility to determine when noncovered versions of a drug should be included in…
The recommendation, in the publisher's words
CMS should seek a legislative change that would provide the agency flexibility to determine when noncovered versions of a drug should be included in Part B payment amount calculations.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- November 21, 2017
- Report
- Excluding Noncovered Versions When Setting Payment for Two Part B Drugs Would Have Resulted in Lower Drug Costs for Medicare and its Beneficiaries (OEI-12-17-00260) · find it at HHS OIG
- Kind of report
- Evaluation
- Agency response
- Non-Concur (as recorded by the publisher)
- Closed
- August 28, 2022 (publisher's date)
- Publisher flags
- Legislative
- Publisher topics
- Financial Stewardship, OIG Statutory Authority and Regulatory Matters, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Acceptable Alternative”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.